Next Article in Journal
Processing Newborn Bloodspot Screening Results for CF
Next Article in Special Issue
Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders
Previous Article in Journal
The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
Previous Article in Special Issue
Development of National Newborn Screening Quality Indicators in the United States
Open AccessCommentary

Universal Implementation of Newborn Screening in India

NeoGen Labs, UCF Center, 84/3 Oil Mill Road, Lingararajpuram, Bengaluru 560 084, Karnataka, India
Int. J. Neonatal Screen. 2020, 6(2), 24; https://doi.org/10.3390/ijns6020024
Received: 24 January 2020 / Revised: 22 March 2020 / Accepted: 24 March 2020 / Published: 25 March 2020
Newborn screening is a successful program in many developed countries. In India, the benefits of dried blood spot screening have been recognized and that screening is slowly gaining traction. There are significant issues standing in the way of universal implementation of a newborn screening program in India: awareness, cost, advocacy, public policy, and politics. Three regional screening programs, Chandigarh, Goa, and Kerala could serve as models for other programs in India. The data for this commentary were based on personal experiences from managing public newborn screening programs, searches on PubMed and Google, and personal interactions with experts in the field. The overwhelming recommendation is to universally screen for congenital hypothyroidism in India, because it is easy and inexpensive to treat, with excellent outcomes. It would also be beneficial to consider screening universally for glucose-6-phosphate dehydrogenase deficiency due to its high incidence and ease of treatment. Finally, sickle cell disease should be screened in those areas in India where it is prevalent due to the costs associated with universal screening. Achieving universal screening is a challenge, and it is very difficult to predict when every baby born in India will be screened for at least congenital hypothyroidism. View Full-Text
Keywords: inborn errors of metabolism; neonatal; newborn screening; population screening; sickle cell disease inborn errors of metabolism; neonatal; newborn screening; population screening; sickle cell disease
MDPI and ACS Style

Mookken, T. Universal Implementation of Newborn Screening in India. Int. J. Neonatal Screen. 2020, 6, 24.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop